AR106004A1 - LOADED NANOPARTICLES WITH ACTIVE INGREDIENTS, THEIR PREPARATION PROCEDURE AND ITS USES - Google Patents

LOADED NANOPARTICLES WITH ACTIVE INGREDIENTS, THEIR PREPARATION PROCEDURE AND ITS USES

Info

Publication number
AR106004A1
AR106004A1 ARP160102794A ARP160102794A AR106004A1 AR 106004 A1 AR106004 A1 AR 106004A1 AR P160102794 A ARP160102794 A AR P160102794A AR P160102794 A ARP160102794 A AR P160102794A AR 106004 A1 AR106004 A1 AR 106004A1
Authority
AR
Argentina
Prior art keywords
active ingredients
preparation procedure
loaded nanoparticles
nanoparticles
loaded
Prior art date
Application number
ARP160102794A
Other languages
Spanish (es)
Inventor
Zandanel Christelle
Original Assignee
Onxeo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onxeo filed Critical Onxeo
Publication of AR106004A1 publication Critical patent/AR106004A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Nanopartículas de uno o varios ingredientes activos, tales como doxorrubicina con diámetro medio controlado, su procedimiento de preparación, sus formulaciones y sus usos terapéuticos.Nanoparticles of one or more active ingredients, such as doxorubicin with controlled mean diameter, its preparation procedure, its formulations and therapeutic uses.

ARP160102794A 2015-09-14 2016-09-13 LOADED NANOPARTICLES WITH ACTIVE INGREDIENTS, THEIR PREPARATION PROCEDURE AND ITS USES AR106004A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15306411 2015-09-14

Publications (1)

Publication Number Publication Date
AR106004A1 true AR106004A1 (en) 2017-11-29

Family

ID=54207433

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160102794A AR106004A1 (en) 2015-09-14 2016-09-13 LOADED NANOPARTICLES WITH ACTIVE INGREDIENTS, THEIR PREPARATION PROCEDURE AND ITS USES

Country Status (3)

Country Link
AR (1) AR106004A1 (en)
TW (1) TW201720447A (en)
WO (1) WO2017046037A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775435B1 (en) * 1998-02-27 2000-05-26 Bioalliance Pharma NANOPARTICLES COMPRISING AT LEAST ONE POLYMER AND AT LEAST ONE COMPOUND CAPABLE OF COMPLEXING ONE OR MORE ACTIVE INGREDIENTS
EP2153821A1 (en) * 2008-08-06 2010-02-17 BioAlliance Pharma Oral formulations of camptothecin derivatives
PL2508207T3 (en) 2011-03-31 2013-09-30 Bioalliance Pharma Nanoparticles loaded with chemotherapeutic antitumoral Drug

Also Published As

Publication number Publication date
WO2017046037A1 (en) 2017-03-23
TW201720447A (en) 2017-06-16

Similar Documents

Publication Publication Date Title
PH12018500714A1 (en) Anti-tigit antigen-binding proteins and methods of use thereof
CL2018001478A1 (en) Apeline receptor agonists and methods of use
MX2023008693A (en) Modulatory polynucleotides.
CL2016002123A1 (en) New polysaccharide and uses thereof
CL2018003425A1 (en) Cannabidiol compositions and uses thereof.
UY37341A (en) FORMULATIONS OF GAMMA-MODIFIED RELEASE HYDROXIBUTIRATE WITH IMPROVED PHARMACOCINETICS
EP3452597A4 (en) Methods and compositions of biologically active agents
EA201792500A1 (en) AAV-MEDIATED EXPRESSION OF ANTIBODIES AGAINST FLU AND METHODS OF THEIR USE
CL2016002300A1 (en) Combinations of active ingredients insecticides and nematocides
MY187540A (en) Compounds active towards bromodomains
BR112016026001A2 (en) BIOCERAMICS COMPOSITIONS AND BIOMODULATING USES OF THEM
BR112016020618A2 (en) antisense oligomer, pharmaceutical composition, and use of an antisense oligomer
CR20140200A (en) SOLID FORMS OF 3- (5-AMINO-2-METHYL-4-OXO-AH-QUINAZOLIN-3-IL) -PIPERIDIN-2,6-DIONA, AND ITS PHARMACEUTICAL COMPOSITIONS AND THEIR USES
CU20170018A7 (en) RORC2 PIRROLOPIRIDINE MODULATORS REPLACED WITH METHYL AND TRIFLUOROMETILO
BR112017003219A2 (en) abiraterone acetate formulation and methods of use
AR109376A1 (en) FORMULATIONS OF MODIFIED LIBERATION G-HYDROXIBUTY
ZA201905431B (en) Electrochemical gasotransmitter generating compositions and methods of using same and dressings and treatment systems incorporating same
MX2019005821A (en) Anti-gitr antigen-binding proteins and methods of use thereof.
BR112017024908A2 (en) therapeutic uses of 4-chloroquinurenine
MX2022005888A (en) Methods of treating ocular conditions.
MX2017013795A (en) Therapeutic combinations of antiviral and anti-inflammatory therapies.
IT201600099380A1 (en) COMPOSITIONS, DEVICES AND METHODS FOR IN VITRO CONTROL OF THE CHEMICAL CELL CROPS MICRO-ENVIRONMENT
PT3471702T (en) Thermostable formulation of biologically active substances
GB2554966B (en) Deodorizing combination of active ingredients
MX2017009313A (en) Intravenous baclofen formulations and treatment methods.

Legal Events

Date Code Title Description
FB Suspension of granting procedure